Ramiro Ribeiro - 02 Jan 2026 Form 4 Insider Report for EyePoint, Inc. (EYPT)

Reporting relationship: Chief Medical Officer
Issuer ticker: EYPT
Reported as of: 02 Jan 2026
Net transaction value: -$111,400
SEC form: 4
Accepted by SEC: 06 Jan 2026, 16:47:59 UTC
Prior SEC filing: 12 Nov 2025
Next SEC filing: 07 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Ron Honig, Attorney-in-Fact

Key filing fact

Ramiro Ribeiro filed Form 4 for EyePoint, Inc. (EYPT) on 06 Jan 2026.

Key facts

This page summarizes Ramiro Ribeiro's Form 4 filing for EyePoint, Inc. (EYPT).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 06 Jan 2026, 16:47.

Change

Previous filing in this sequence was filed on 12 Nov 2025.
Current net transaction value: -$111,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013623 Primary reporting owner

Ribeiro Ramiro

Relationship: Chief Medical Officer
Address: C/O EYEPOINT, INC, 480 PLEASANT STREET, SUITE C400, WATERTOWN
Signature: /s/ Ron Honig, Attorney-in-Fact
Signature date: 06 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EYPT transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +19,667
Change %
Price: $0.000000
Shares after: 19,667
Date: 03 Jan 2026
Ownership: Direct

EYPT transaction

Common Stock

Tax liability

Transaction value: $111,400
Shares: -6,373
Change %: -32%
Price: $17.48
Shares after: 13,294
Date: 03 Jan 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EYPT transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +85,700
Change %
Price: $0.000000
Shares after: 85,700
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 85,700
Exercise price: $0.000000
Footnotes: F2

EYPT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +171,400
Change %
Price: $0.000000
Shares after: 171,400
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 171,400
Exercise price: $17.48
Footnotes: F3

EYPT transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -19,667
Change %: -33%
Price: $0.000000
Shares after: 39,333
Date: 03 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,667
Exercise price: $0.000000
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.

Footnote F2

The restricted stock units will vest in three ratable annual installments beginning January 2, 2027.

Footnote F3

The option to purchase will vest and become exercisable as follows: 25% at January 2, 2027 and the remainder ratably, on a monthly basis, over the remaining three years.

Footnote F4

The restricted stock units vest in three ratable annual installments beginning January 3, 2026.